Current evidence from preclinical models suggests that TLR2 and the AIM2 cytosolic DNA sensor drive gastric tumorigenesis, independent of inflammation, by cancer cell autonomous mechanisms that augment the proliferation and survival (TLR2), as well as migration (AIM2), of the gastric tumor epithelium (13, 17). This evidence concerns the gene AIM2 and gastric neoplasm.